Fields | Project/Modality | Target | Indications | Pre-clinical | Phase Ⅰ | Phase Ⅱ | Phase Ⅲ | Trial Regions | Rights Regions | Partner |
---|---|---|---|---|---|---|---|---|---|---|
Nephropathy | SC0062 SM |
ETA | lgA | |||||||
DKD | ||||||||||
Oncology | BC3195 ADC |
CDH3 | Soild tumor | |||||||
Oncology | BC3402 mAb |
TIM-3 | HCC | |||||||
MDS/CMML | ||||||||||
Oncology | SC0245 SM |
ATR | Solid tumor | |||||||
SCLC | ||||||||||
Oncology | SC0191 SM |
WEE1 | Solid tumor | |||||||
Solid tumor | ||||||||||
OC | ||||||||||
Oncology | BC3448 BsAb |
CD3xEGFR | Solid tumor | |||||||
Oncology | BC3425 mAb |
4-1BB | Solid tumor | |||||||
Oncology | ADC | Undisclosed | Solid tumor | |||||||
Oncology | Bs-Ab | Undisclosed | Solid tumor |